1609.HK
Star Sports Medicine Co., Ltd.

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

625.86M USD

Market Cap

558.28M USD

Margin of Safety

10.8%

Intrinsic / Market Ratio

1.12×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

379.17M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

427.82M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.07B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

625.86M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

625.86M USD

from the sum above

Market Cap

558.28M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.12×

the ratio the screener ranks by; Margin of Safety +10.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 379.17M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)152.57M USD
+②Net Cash Today160.79M USD
+③Growth Value65.82M USD
=Value379.17M USD

EPV of the Operations (NOPAT over WACC)

152.57M USD

Net cash today

+160.79M USD

Growth Value

+65.82M USD

Value

379.17M USD

①EPV (earnings power value)

152.57M USD

②Net Cash Today

160.79M USD

③Growth Value

65.82M USD

Market value

Market Cap558.28M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-47.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 427.82M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE257.94M USD
+②Equity at Year 15, Today169.88M USD
=Value427.82M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

257.94M USD

②Equity at Year 15, Today

169.88M USD

Market value

Market Cap558.28M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-30.5%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.07B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF792.24M USD
+②Invested Capital at Year 15, Today117.56M USD
+③Net Cash Today160.79M USD
=Value1.07B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

792.24M USD

②Invested Capital at Year 15, Today

117.56M USD

③Net Cash Today

160.79M USD

Market value

Market Cap558.28M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+47.9%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.42%
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 2.46M USDPretax Income 22.06M USD= 11.16%

The tax the interest saves.

Interest Expense =EBIT 22.11M USD−Pretax Income 22.06M USD= 49.08K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 49.08K USDTotal Debt 4.59M USD×(1 − Tax Rate for WACC 11.16%)= 0.95%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 4.59M USDMarket Cap + Total Debt 558.28M USD + 4.59M USD= 0.82%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.18%×Cost of Equity 10.50%+Debt Weight 0.82%×Cost of Debt 0.95%= 10.42%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 211.17M USD − Total Liabilities 19.31M USD = Book Value Today 191.85M USD

Total Debt 4.59M USD − Cash and Short-Term Investments 165.38M USD = Net Debt Today -160.79M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.0%at most 5%passes54,831,344 / 54,831,344
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets1.4%at least -10.0%passes(22.48M USD − 19.60M USD) ÷ 211.17M USD
Price to bookMarket Cap ÷ Book Value Today2.91×at most 3×passes558.28M USD ÷ 191.85M USD
Operating marginOperating Income ÷ Revenue40.6%above 10.0%passes23.39M USD ÷ 57.63M USD
Revenue growthRevenue ÷ Revenue a Year Before − 128.4%above 10.0%passes57.63M USD / 44.87M USD
Net cash(Cash − Total Debt) ÷ Market Cap20.8%above -30%passes(120.77M USD − 4.59M USD) ÷ 558.28M USD
Operating efficiencyOperating Income ÷ Gross Profit54.7%above 25.0%passes23.39M USD ÷ 42.73M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

79.88 HKD

Enterprise value

3.42B HKD

the provider's own figure

EV / EBITDA

23.82×

Price / book

5.19×

the provider's book

Price / earnings

29.45×

Return on equity

25.4%

the provider's figure, not this page's

Profit margin

34.0%

Revenue growth

—

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

21.07M33.60M44.87M57.63M

Gross profit

14.94M24.97M31.22M42.73M

Operating income

5.02M8.42M14.04M23.39M

EBITDA

operating income before depreciation and amortisation

6.95M10.94M16.71M24.23M

Pretax income

5.84M9.06M14.75M22.06M

Net income

5.80M8.04M13.08M19.60M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

5.61M8.03M13.10M21.43M

R&D

2.63M4.93M5.11M6.80M
Balance sheet, year end

Total assets

49.87M63.56M84.67M109.32M

Total liabilities

2.69M10.78M20.04M22.13M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

47.19M52.78M64.63M87.20M

Total debt

1.59M1.17M3.10M4.67M

Cash and equivalents

39.22M50.19M12.34M16.72M

Net PP&E

fixed assets after depreciation

4.27M5.70M12.24M12.62M

Working capital

current assets less current liabilities

36.52M47.13M54.20M75.66M
Cash flow

Operating cash flow

8.02M11.25M12.96M22.48M

Capital expenditure

paid out, so below zero

-1.22M-2.99M-3.73M-4.90M

Depreciation and amortisation

1.03M1.81M1.91M2.12M

Free cash flow

operating cash flow plus capital expenditure

6.80M8.25M9.24M17.58M